{{Drugbox
| verifiedrevid = 
| IUPAC_name = 3-Allyl-5-isobutyl-2-thioxo-4-imidazolidinone
| image=Albutoin.svg
| width=
| CAS_number= 830-89-7
| ATC_prefix=
| ATC_suffix= 
| ATC_supplemental=
| PubChem=3032361
| DrugBank= 
| ChemSpiderID=2297355 
| C=10 | H=16 | N=2 | O=1 | S=1
| bioavailability= 
| metabolism = 
| elimination_half-life=
| excretion =  
| pregnancy_category = 
| legal_status = 
| routes_of_administration= 
| smiles = S=C1N(C(=O)C(N1)CC(C)C)C\C=C
| synonyms = BAX-422Z<ref name="Elks2014" />
}}

'''Albutoin''' ([[International Nonproprietary Name|INN]], [[United States Adopted Name|USAN]]) is an [[anticonvulsant]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA24|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=24–}}</ref><ref>{{Cite journal | pmid=4206927| year=1974| author1=Cereghino| first1=J. J.| title=Evaluation of albutoin as an antiepileptic drug| journal=Clinical pharmacology and therapeutics| volume=15| issue=4| pages=406–16| last2=Brock| first2=J. T.| last3=Van Meter| first3=J. C.| last4=Penry| first4=J. K.| last5=Smith| first5=L. D.| last6=Fisher| first6=P| last7=Ellenberg| first7=J}}</ref> It was marketed in [[Europe]] as '''CO-ORD''' and '''Euprax''' by [[Baxter Laboratories]].<ref name="Elks2014" /> It was evaluated by the [[United States Food and Drug Administration]], but not approved.<ref>{{cite journal | doi = 10.1111/j.1528-1167.2009.02042.x| pmid = 19298435| title = Drug treatment of epilepsy in the century of the ILAE: The second 50 years, 1959-2009| journal = Epilepsia| volume = 50| pages = 93–130| year = 2009| last1 = Shorvon| first1 = Simon D.}}</ref>

==References==
{{Reflist|2}}


{{Anticonvulsants}}

[[Category:Anticonvulsants]]
[[Category:Allyl compounds]]


{{anticonvulsant-stub}}